ELV
Elevance Health, Inc.
Stock
$386.43+4.76 (+1.25%)Close Oct 2, 2026
- Net income, 2025
- $5.7B
- YoY, 2025
- −5.3%
- 5-year CAGR
- +4.4%
- 10-year CAGR
- +8.3%
Net income
Net income by fiscal year
| Period | Net income | YoY |
|---|---|---|
| 2025 | $5.7B | −5.3% |
| 2024 | $6.0B | −0.1% |
| 2023 | $6.0B | +1.6% |
| 2022 | $5.9B | −4.3% |
| 2021 | $6.2B | +34.7% |
| 2020 | $4.6B | −4.9% |
| 2019 | $4.8B | +28.2% |
| 2018 | $3.8B | −2.4% |
| 2017 | $3.8B | +55.6% |
| 2016 | $2.5B | −3.5% |
| 2015 | $2.6B | −0.4% |
| 2014 | $2.6B | +3.2% |
| 2013 | $2.5B | −6.2% |
| 2012 | $2.7B | +0.3% |
| 2011 | $2.6B | −8.3% |
| 2010 | $2.9B | −39.2% |
| 2009 | $4.7B | +90.5% |
| 2008 | $2.5B | −25.5% |
| 2007 | $3.3B | — |